Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Br J Pharmacol ; 165(3): 765-76, 2012 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-21797843

RESUMEN

BACKGROUND AND PURPOSE: Leukotrienes (LTs) are pro-inflammatory mediators produced by 5-lipoxygenase (5-LO). Currently available 5-LO inhibitors either lack efficacy or are toxic and novel approaches are required to establish a successful anti-LT therapy. Here we provide a detailed evaluation of the effectiveness of the plant-derived alkaloid tryptanthrin as an inhibitor of LT biosynthesis. EXPERIMENTAL APPROACH: We analysed LT formation and performed mechanistic studies in human neutrophils stimulated with pathophysiologically relevant stimuli (LPS and formyl peptide), as well as in cell-free assays (neutrophil homogenates or recombinant human 5-LO) and in human whole blood. The in vivo effectiveness of tryptanthrin was evaluated in the rat model of carrageenan-induced pleurisy. KEY RESULTS: Tryptanthrin potently reduced LT-formation in human neutrophils (IC(50) = 0.6µM). However, tryptanthrin is not a redox-active compound and did not directly interfere with 5-LO activity in cell-free assays. Similarly, tryptanthrin did not inhibit the release of arachidonic acid, the activation of MAPKs, or the increase in [Ca(2+) ](i) , but it modified the subcellular localization of 5-LO. Moreover, tryptanthrin potently suppressed LT formation in human whole blood (IC(50) = 10µM) and reduced LTB(4) levels in the rat pleurisy model after a single oral dose of 10mg·kg(-1) . CONCLUSIONS AND IMPLICATIONS: Our data reveal that tryptanthrin is a potent natural inhibitor of cellular LT biosynthesis with proven efficacy in whole blood and is effective in vivo after oral administration. Its unique pharmacological profile supports further analysis to exploit its pharmacological potential.


Asunto(s)
Antiinflamatorios/farmacología , Araquidonato 5-Lipooxigenasa/metabolismo , Antagonistas de Leucotrieno/farmacología , Neutrófilos/efectos de los fármacos , Pleuresia/metabolismo , Quinazolinas/farmacología , Adulto , Animales , Antiinflamatorios/uso terapéutico , Calcio/metabolismo , Carragenina , Células Cultivadas , Medicamentos Herbarios Chinos , Humanos , Antagonistas de Leucotrieno/uso terapéutico , Leucotrienos/metabolismo , Masculino , Proteínas Quinasas Activadas por Mitógenos/metabolismo , Neutrófilos/metabolismo , Pleuresia/inducido químicamente , Pleuresia/tratamiento farmacológico , Quinazolinas/uso terapéutico , Ratas , Ratas Wistar , Especies Reactivas de Oxígeno/metabolismo
2.
Phytomedicine ; 9(6): 530-5, 2002 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-12403162

RESUMEN

The effect of an ethanolic extract of propolis, with and without CAPE, and some of its components on cyclooxygenase (COX-1 and COX-2) activity in J774 macrophages has been investigated. COX-1 and COX-2 activity, measaured as prostaglandin E2 (PGE2) production, were concentration-dependently inhibited by propolis (3 x 10(-3) - 3 x 10(2) microgml(-1)) with an IC50 of 2.7 microgml(-1) and 4.8 x 10(-2) microgml(-1), respectively. Among the compounds tested pinocembrin and caffeic, ferulic, cinnamic and chlorogenic acids did not affect the activity of COX isoforms. Conversely, CAPE (2.8 x 10(-4) - 28 microgml(-1); 10(-9) - 10(-4) M) and galangin (2.7 x 10(-4) - 27 microgml(-1); 10(-9) - 10(-4) M) were effective, the last being about ten-twenty times less potent. In fact the IC50 of CAPE for COX-1 and COX-2 were 4.4 x 10(-1) microgml(-1) (1.5 x 10(-6) M) and 2 x 10(-3) microgml(-1) (6.3 x 10(-9) M), respectively. The IC50 of galangin were 3.7 microgml(-1) (15 x 10(-6) M) and 3 x 10(-2) microgml(-1) (120 x 10(-9) M), for COX-1 and COX-2 respectively. To better investigate the role of CAPE, we tested the action of the ethanolic extract of propolis deprived of CAPE, which resulted about ten times less potent than the extract with CAPE in the inhibition of both COX-1 and COX-2, with an IC50 of 30 microgml(-1) and 5.3 x 10(-1) microgml(-1), respectively. Moreover the comparison of the inhibition curves showed a significant difference (p < 0.001). These results suggest that both CAPE and galangin contribute to the overall activity of propolis, CAPE being more effective.


Asunto(s)
Ácidos Cafeicos/farmacología , Isoenzimas/metabolismo , Macrófagos/efectos de los fármacos , Alcohol Feniletílico/análogos & derivados , Alcohol Feniletílico/farmacología , Própolis/farmacología , Prostaglandina-Endoperóxido Sintasas/metabolismo , Animales , Línea Celular , Ciclooxigenasa 1 , Ciclooxigenasa 2 , Dinoprostona/metabolismo , Relación Dosis-Respuesta a Droga , Flavonoides/metabolismo , Flavonoides/farmacología , Isoenzimas/efectos de los fármacos , Macrófagos/enzimología , Macrófagos/metabolismo , Prostaglandina-Endoperóxido Sintasas/efectos de los fármacos
3.
Inflamm Res ; 49(8): 411-7, 2000 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-11028758

RESUMEN

OBJECTIVE AND DESIGN: The role of nitric oxide (NO) on leucocyte migration has been investigated in rat carrageenin-induced pleurisy. MATERIAL: Male Wistar rats. TREATMENT: L-arginine, NOC-18 and aminoguanidine were administered subcutaneously 1 h prior to carrageenin injection. METHODS: Leucocyte accumulation into the pleural cavity was measured 4 h after carrageenin challenge. Statistical significance was calculated by Bonferroni test. RESULTS: L-arginine (10 mg/kg) or the NO donor NOC-18 (10 mg/kg), significantly inhibited leucocyte infiltration by 31% and 20% respectively (P<0.01). On the contrary, when these compounds were given at high doses (L-arginine 300 mg/kg; NOC-18 30 mg/kg), leucocyte accumulation was increased by 22% and 33% respectively (P<0.01). Aminoguanidine, a relatively selective inhibitor of the inducible NO synthase, depending on the dose, showed a biphasic effect on cell migration. Thus, at low doses (30 and 100 mg/kg), aminoguanidine increased (by 40% and 74% respectively, P< 0.01) leucocyte infiltration which was inhibited by 41% (P < 0.01) when the drug was given at high dose (300 mg/kg). CONCLUSIONS: These results suggest that in rat carrageenin-induced pleurisy NO primarily inhibits leucocyte migration.


Asunto(s)
Carragenina , Movimiento Celular/efectos de los fármacos , Leucocitos/fisiología , Óxido Nítrico/farmacología , Pleuresia/patología , Animales , Arginina/administración & dosificación , Arginina/farmacología , Presión Sanguínea , Inhibidores Enzimáticos/farmacología , Guanidinas/administración & dosificación , Guanidinas/farmacología , Masculino , Donantes de Óxido Nítrico/administración & dosificación , Donantes de Óxido Nítrico/farmacología , Óxido Nítrico Sintasa/antagonistas & inhibidores , Óxido Nítrico Sintasa de Tipo II , Compuestos Nitrosos/administración & dosificación , Compuestos Nitrosos/farmacología , Pleura/patología , Derrame Pleural/patología , Derrame Pleural/fisiopatología , Pleuresia/inducido químicamente , Ratas , Ratas Wistar
4.
Fitoterapia ; 71 Suppl 1: S48-57, 2000 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-10930713

RESUMEN

Non-steroidal anti-inflammatory drugs (NSAIDs) are among the most used drugs worldwide, in spite of their renal and gastric side effects. Medicinal plants may represent a useful source of new effective therapeutic agents, particularly considering the new findings concerning the mediators of inflammation, such as prostaglandins and nitric oxide. In fact, the discovery of two isoforms of the enzyme cyclooxygenase, which catalyzes the conversion of arachidonic acid to prostaglandins, has opened new interesting perspectives in the treatment of inflammatory diseases. As cyclooxygenase, also nitric oxide synthase, the enzyme which converts L-arginine to nitric oxide, exists in two isoforms. It appears that the constitutive isoforms of both enzymes (cyclooxygenase-1 and constitutive nitric oxide synthase) have a regulatory-physiological role, whereas the inducible isoforms (cyclooxygenase-2 and inducible nitric oxide synthase) are involved in inflammation. A number of medicinal plants have been screened for their ability to inhibit cyclooxygenase-2 and/or inducible nitric oxide synthase activity and/or expression.


Asunto(s)
Antiinflamatorios no Esteroideos/uso terapéutico , Inhibidores de la Ciclooxigenasa/uso terapéutico , Óxido Nítrico Sintasa/antagonistas & inhibidores , Fitoterapia , Plantas Medicinales , Humanos , Óxido Nítrico Sintasa de Tipo II , Extractos Vegetales/uso terapéutico , Prostaglandinas/fisiología
5.
Eur J Pharmacol ; 368(1): 43-8, 1999 Feb 26.
Artículo en Inglés | MEDLINE | ID: mdl-10096768

RESUMEN

The role of nitric oxide (NO) on aloe-induced diarrhoea was studied in the rat. Nine hours after oral administration, aloe produced diarrhoea at doses of 5 g kg(-1)(20% rats with diarrhoea) and 20 g kg(-1) (100% of rats with diarrhoea). Lower doses of aloe (0.1 and 1 g kg(-1) did not produce a diarrhoeal response. Pre-treatment (i.p.) of rats with the NO synthase inhibitor N(G)-nitro-L-arginine methyl ester (L-NAME 2.5-25 mg kg(-1) reduced the diarrhoea induced by aloe (20 g kg(-1) 9 h after its oral administration. L-NAME (25 mg kg(-1)) also reduced the increase in faecal water excretion produced by aloe (20 g kg(-1). L-arginine (1500 mg kg(-1), i.p.), administered to rats pre-treated with L-NAME (25 mg kg(-1), drastically reduced the effect of L-NAME on diarrhoea and increase in faecal water excretion induced by aloe (20 g kg(-1). Given alone, L-arginine did not modify aloe-induced diarrhoea. Basal Ca2+ -dependent NO synthase activity in the rat colon was dose-dependently inhibited by aloe (0.1-20 g kg(-1)) and by aloin (0.1-1 g kg(-1)), the active ingredient of aloe. These results suggest that endogenous NO modulates the diarrhoeal effect of aloe.


Asunto(s)
Aloe/efectos adversos , Diarrea/fisiopatología , Óxido Nítrico/fisiología , Plantas Medicinales , Animales , Arginina/farmacología , Agua Corporal/efectos de los fármacos , Agua Corporal/metabolismo , Quelantes/farmacología , Defecación/efectos de los fármacos , Diarrea/inducido químicamente , Diarrea/prevención & control , Relación Dosis-Respuesta a Droga , Ácido Egtácico/farmacología , Inhibidores Enzimáticos/farmacología , Heces/química , Masculino , NG-Nitroarginina Metil Éster/farmacología , Óxido Nítrico Sintasa/antagonistas & inhibidores , Ratas , Ratas Wistar , omega-N-Metilarginina/farmacología
6.
Eur J Pharmacol ; 323(1): 93-7, 1997 Mar 26.
Artículo en Inglés | MEDLINE | ID: mdl-9105882

RESUMEN

The role of constitutive and inducible nitric oxide (NO) synthase in rats treated with senna and cascara was studied. Senna (60 mg/kg p.o.) and cascara (800 mg/kg p.o.) ex vivo significantly increased Ca(2+)-dependent constitutive NO synthase activity in the rat colon. Induction of NO synthase (12% of the total NO synthase) was associated with cascara, but not senna, administration. Dexamethasone (0.03-0.3 mg/kg i.p.), which inhibits the expression of inducible NO synthase, significantly and dose-dependently reduced cascara-(but not senna-) induced diarrhoea and colonic fluid secretion. These findings suggest that senna probably exerts its laxative effect through stimulation of the constitutive isoform of NO synthase, while the inducible isoform of NO synthase also seems to be involved in the laxative effect of cascara.


Asunto(s)
Catárticos/toxicidad , Colon/efectos de los fármacos , Diarrea/inducido químicamente , Óxido Nítrico Sintasa/biosíntesis , Rhamnus/toxicidad , Extracto de Senna/toxicidad , Administración Oral , Análisis de Varianza , Animales , Antiinflamatorios/administración & dosificación , Antiinflamatorios/farmacología , Antiinflamatorios/uso terapéutico , Catárticos/administración & dosificación , Colon/enzimología , Dexametasona/administración & dosificación , Dexametasona/farmacología , Dexametasona/uso terapéutico , Diarrea/tratamiento farmacológico , Relación Dosis-Respuesta a Droga , Inducción Enzimática/efectos de los fármacos , Inyecciones Intraperitoneales , Absorción Intestinal/efectos de los fármacos , Isoenzimas , Masculino , Óxido Nítrico Sintasa/metabolismo , Ratas , Ratas Wistar , Rhamnus/administración & dosificación , Extracto de Senna/administración & dosificación , Agua/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA